Skip to main content
NCBI home page
Microbial Biotechnology logoLink to Microbial Biotechnology
. 2015 Jan 8;8(2):230–238. doi: 10.1111/1751-7915.12189

A rapid enzymatic assay for high-throughput screening of adenosine-producing strains

Huina Dong 1,2,†, Xin Zu 1,3,†, Ping Zheng 1,2, Dawei Zhang 1,2,*
PMCID: PMC4353337  PMID: 25580842

Abstract

Adenosine is a major local regulator of tissue function and industrially useful as precursor for the production of medicinal nucleoside substances. High-throughput screening of adenosine overproducers is important for industrial microorganism breeding. An enzymatic assay of adenosine was developed by combined adenosine deaminase (ADA) with indophenol method. The ADA catalyzes the cleavage of adenosine to inosine and NH3, the latter can be accurately determined by indophenol method. The assay system was optimized to deliver a good performance and could tolerate the addition of inorganic salts and many nutrition components to the assay mixtures. Adenosine could be accurately determined by this assay using 96-well microplates. Spike and recovery tests showed that this assay can accurately and reproducibly determine increases in adenosine in fermentation broth without any pretreatment to remove proteins and potentially interfering low-molecular-weight molecules. This assay was also applied to high-throughput screening for high adenosine-producing strains. The high selectivity and accuracy of the ADA assay provides rapid and high-throughput analysis of adenosine in large numbers of samples.

Introduction

Adenosine, an endogenous purine nucleoside, is a conventional drug in the emergency treatment of arrhythmia and drug load test. It antagonizes many of the biochemical and physiological mechanisms implicated in ischemia-reperfusion injury and has been shown to reduce postischemic ventricular dysfunction and myocyte necrosis and apoptosis (Olafsson et al., 1987; Kaminski and Proctor, 1989; Meldrum, 1998). It also has been proved to enhance myocardial ischemia tolerance, reduce myocardial reperfusion injury and decrease the infarction area (Lawson et al., 1993; Marzilli et al., 2000). Meanwhile, adenosine is an important pharmaceutical intermediate that can be used for synthesis of variety of medicinal nucleoside substances, such as adenosine triphosphate (ATP) (Asada et al., 1981).

Microbial production of adenosine has drawn more attention recently because of its cost effectiveness and environmentally friendly production process in comparison with chemical production processes. The mass production of adenosine has been focused on the field of microbial production processes development through metabolic engineering and strain breeding. Bacillus subtilis is one of the candidates for industrial production of adenosine (Nishiyama et al., 1995; Yu et al., 2011; Chen et al., 2013), which also has a long history as a safe and stable producer of inosine, guanosine and valuable enzymes in commercial processes (Sauer et al., 1998; Dong and Zhang, 2014; Zhang et al., 2014).

Traditionally, industrial microorganism breeding has been developed via multiple rounds of random mutagenesis by ultraviolet radiation, diethyl sulfate treatment, or low energy ions mutations. The concentration of adenosine was usually measured using High-performance liquid chromatography (HPLC) (Chen et al., 2013). HPLC can accurately quantify trace adenosine but require pretreatments to remove proteins or other molecules prior to analysis. Expensive and bulky instruments are required and the samples should be measured one after another. In clinical area, several methods has been developed to determine adenosine in urine or tissues, such as method using reduced S-adenosylhomocysteine hydrolase (Kloor et al., 2000), firefly luciferase-based assay (Burgos et al., 2012), enzyme- coupled assays (Helenius et al., 2012) and aptamer Sensor based methods (Hu et al., 2012; Li et al., 2012; Wang et al., 2012; Fu et al., 2013; Zhang et al., 2013). However, these methods are not suitable to the detection of large numbers of fermentation samples because of their narrow detection range or high test cost. Therefore, there is an urgent need for the development of accurate and rapid screening method after cell mutagenesis.

An enzymatic assay is one of the promising solutions (Hisamatsu et al., 2012) because it can analyze multiple samples simultaneously without any specialized, bulky, and expensive instruments. Adenosine deaminase (ADA; EC 3.5.4.4) participates in purine metabolism where it degrades either adenosine or 2′-deoxyadenosine to inosine or 2′-deoxyinosine, respectively (Eq. 1 and 2).

graphic file with name mbt20008-0230-m1.jpg 1
graphic file with name mbt20008-0230-m2.jpg 2

To develop a simple and rapid adenosine assay, ADA represented one of the promising enzymes. Several methods have been used to detect the resulting ammonia, such as ion-exchange method (Dienst, 1961; Thomas et al., 2002), dry-film method using diffuse separation (Iosefsohn and Hicks, 1985; Diaz et al., 1995), indophenol method (Berthelot method) (Ngo et al., 1982), microfluorescence assay using phthalaldehyde and mercaptoethanol (Taylor et al., 1974; Mroz et al., 1982). Enzymatic methods using glutamate dehydrogenase (GLDH) (Talke and Schubert, 1961; Tanganelli et al., 1982; da Fonseca-Wollheim and Heinze, 1992), l-glutamine synthetase (GS) (Wakisaka et al., 1987) and a enzymatic cycling system composed of three enzymes [NAD synthetase (NADS), glucose dehydrogenase (GlcDH), and diaphorase (DI)] (Yamaguchi et al., 2005) have also been developed. In particular, the indophenol method has been widely utilized for clinical and food analyses.

Here we describe an assay method based on ADA to detect adenosine and to improve the efficiency for screening of high adenosine-producing strains. This method combines ADA with indophenol method. The variation of resulting blue color can be monitored via OD697 and high-throughput screening can be achieved using 96-well plates. The ADA assay was successfully applied to measure adenosine in broth of adenosine-producing B. subtilis strain and verified by HPLC evaluation. The high-throughput screening of adenosine-producing strain was also discussed.

Results

Expression and purification of ADA in Escherichia coli

As shown in Fig. 1, adenosine deaminase gene was amplified from E. coli 1655 genomic DNA and inserted into pET28a vector, yielding pET28a-add. The pET28a-add was expressed in E. coli BL21(DE3) and induced by IPTG. The induced protein migrated as a 40.6 kDa protein on SDS-PAGE gel. It was shown that most of the induced protein was soluble after purification. The specific activity of purified ADA was estimated to be 15.5 U/mg. Purified ADA was used for the construction of enzymatic assays to detect adenosine as below.

Figure 1.

Figure 1

Open in a new tab

SDS-PAGE analysis of the ADA expression. E. coli BL21(DE3) cells containing pET-28a-add were grown and induced with 1 mM IPTG. The cells were sonicated and then centrifuged to divide into two fractions, soluble and insoluble fractions. Soluble fractions were then purified using Ni-NTA agarose. Lane 1, size markers; Lane 2, total proteins of the uninduced cells; Lane 3, total proteins of the IPTG-induced cells; Lane 4, purified protein of ADA.

Activity determination of ADA

The activity determination of ADA was conducted. The expressed ADA has a strong deamination activity to adenosine in comparison with the control group, which lacks ADA. Although blank samples generated a little background signal, the expressed ADA still showed a distinguished activity.

Determination of adenosine based on ADA

The adenosine assay was developed by coupling ADA to indophenol method. The resulting indophenol has a maximum absorption at 697 nm. The addition of adenosine resulted in a proportional color development giving a linear standard curve (Fig. 2). The linear range and detection limit in H2O, LB and M9 media are listed in Table 1. We also showed Signal to background ratios (S/B) generated by the standard curves in different media to present the sensitivity of the ADA method for broth detection in Table 1. The regular M9 medium contains (NH4)2SO4, in which the concentration of NH4+ was higher than that produced in ADA reaction. The regular M9 has a significant influence on ADA reaction (Fig. S1). Therefore, we replaced it with urea. The modified M9 medium enabled the highly sensitive detection of a low concentration of adenosine. The LB medium has negative influence on the assay, while the influence will significantly decrease as the medium was diluted 10-fold (Fig. 2F and G). Therefore, the fermentation samples in LB medium should be diluted before ADA reaction and the dilution step is a necessary step when LB is used.

Figure 2.

Figure 2

Open in a new tab

Adenosine standard curves using ADA assay in H2O (A and B), modified M9 medium (C and D), LB medium (E) and 10-fold diluted LB medium (F and G), respectively. Each plot represents the average of three samples. Absorbance was measured using a micro-plate reader.

Table 1.

Summary of parameters of the adenosine assay by ADA

H2O M9 medium LB medium 10 fold diluted LB medium
Linear range of adenosine concentrations (mM) 0.065–10 0.054–10 3.2–10 0.098–10
Detection limit (mM) 0.065 0.054 3.2 0.098
Z′(calculated with 1 and 10 mM) 0.881 0.911 0.652 0.902
Concentration of adenosine/mM S/B(H2O) S/B(M9 medium) S/B(LB medium) S/B(10-fold diluted LB medium)
0.01 1.08 2.76 1.03
0.025 1.19 2.90 1.03
0.05 1.38 3.08 1.07
0.075 1.51 3.29 1.07
0.1 1.66 3.56 1.08
0.25 2.66 4.80 1.23
0.5 4.31 6.88 1.44 1.44
0.75 6.14 9.27 1.46 1.66
1 7.79 11.65 1.50 1.89
2 14.37 16.97 1.61 2.82
3 19.59 24.69 1.73 3.83
4 24.80 32.62 1.84 4.64
5 31.15 38.84 1.95 5.27
6 36.31 47.54 2.01 6.29
7 42.47 54.51 2.11 7.02
8 47.33 62.92 2.21 7.79
9 52.85 65.68 2.30 8.97
10 58.54 71.32 2.35 9.51
Open in a new tab

Substrate specificity test of ADA

The deamination activity of ADA was examined with various nucIeotide-related substances including adenosine, 2′-deoxyadenosine, cytidine, uridine, thymidine, guanosine, adenine, inosine, ATP, ADP, AMP and IMP. The adenosine deaminase catalyzed the deamination of deoxyadenosine besides adenosine And the absorbance of 2′-deoxyadenosine was 1.15-fold of adenosine. It revealed no deamination activity with other kinds of ribonucleosides, especially AMP and IMP, which are the by-products in the fermentation of adenosine-producing strain (Yu et al., 2011). Adenine arabinoside, 3′-deoxyadenosine and 2′-deoxyadenosine are the alternative substrates for adenosine (Nygaard, 1978). In general, the enzymatic steps in the de novo biosynthetic pathways of pyrimidine nucleotides are regulated in vivo by feedback inhibition of key enzymes, and by repression and/or attenuation of enzyme synthesis by the accumulation of end products or other metabolites (Roland et al., 1985). Accordingly, pyrimidine nucleosides such as deoxyadenosine, which could theoretically be synthesized from the end products (pyrimidine nucleotides), are almost impossible to secrete out of cells and accumulate in media. Thus, ADA could be used to determine specifically the amount of adenosine in fermentation broth.

Effect of medium components on the adenosine assay

A number of compounds including common media components, some precursors and by-products of adenosine production, were tested for possible interference to ADA assay (Table 2). It is shown that most of components do not interfere the assay. The xylose strongly suppress the development of blue color. The multiple nutrition components including beef power, tryptone, yeast extract and yeast power had some influence on the accuracy of ADA assay (126.5% ∼ 225.4%). The error may be caused by endogenous components with amino functional groups contained in these complicated components. Zn2+, Co2+, Ca2+ and Mn2+ cause an increase in absorbance at high concentration, however, when they were at low concentration the influence will decrease (data not shown). The influence of metal ions contained in medium can be ignored as their concentration were lower compared with the experimental concentration.

Table 2.

Effect of medium components on adenosine assay

compound Concentration (mM) % absorbance compound Concentration (g/l) % absorbance
Mineral salts Nutritional components
NaCl 10 98.3 Beef powder 5 225.4
ZnCl2 10 124.5 Tryptone 5 137.2
CoCl2 10 120.9 Yeast extract 5 126.5
FeCl3 10 108.2 Yeast powder 5 219.7
CuCl2 10 90.9 Lactose 10 92.0
CaSO4 10 117.9 Maltose 10 104.1
MnSO4 10 125.8 Sucrose 10 95.7
Na2SO4 10 94.3 D-glucose 10 88.5
FeSO4 10 102.0 D-xylose 10 60.9
CuSO4 10 87.6 L-arabinose 10 98.2
Sodium acetate 10 96.5 D-Mannitol 10 99.9
NaHCO3 10 72.1 D-Sorbitol 10 95.2
NaNO2 10 73.2 Urea 10 106.0
Sodium citrate 10 91.3 Betaine 10 96.4
Calcium carbonate 10 94.4 Tryptophan 2 110.6
sodium pyruvate 10 94.1 AMP 2 108.5
sodium lactate 10 97.4
M9 102.9 LB 67.5
10-fold diluted LB 101.9
Open in a new tab

Note: Values reported in the table were the average of three parallel determinations. The absorbance was reported as a percentage of that obtained with adenosine, (2 mM) dissolved in water, i.e., [(absorbance with adenosine + test compound)/absorbance with adenosine alone] × 100%. A value of 100 means no interference; a value of 0 means total interference, i.e., no color formation at all, and values greater than 100 mean the test compound enhances the absorbance of the solution.

In the above experiments, each component is separately tested in water, the M9 and LB media are the examples (Table 2) to show the extent of interference from real media situation. Additive and synergetic effects could potentially happen when several of these molecules are together. The result showed that the LB medium had inhibition on the ADA assay. The diluted LB in Fig. 2 had decreased inhibition on ADA assay, thus the fermentation broth should be diluted before ADA assay when complex media are used.

Spike and recovery test with fermentation broth

To verify whether the ADA assay was applicable to detect the increase of adenosine in fermentation broth, a time course of adenosine production by adenosine-producing strain was shown in Fig. 3A. The results showed that the ADA assay fit well with HPLC method. Considering fermentation time, and the by-products and other metabolites produced in fermentation, fermentation samples at 24 h were chosen to detect adenosine for screening adenosine-production strains.

Figure 3.

Figure 3

Open in a new tab

A. Adenosine concentration in the fermentation flask determined using the CDA assay and HPLC.B. Correlation between the enzymatic determination of adenosine and adenosine added concentration in fermentation broth.Each experiment run in triplicate.

The reliability of the ADA assay was further supported by the assay results of adding 0–2 mM adenosine to the fermentation broth at 24 h. The assay estimated the intrinsic adenosine concentration in the fermentation sample to be 1.05 ± 0.05 mM. This value was consistent with that estimated by instrumental analysis (HPLC), 0.97 ± 0.002 mM, confirming the accuracy of the ADA assay in biological samples. As shown in Fig. 3B, good linearity (R2 = 0.9951) was obtained between the concentration of adenosine added in fermentation broth. From the slope of linear correlation, the recovery of adenosine by ADA determination was 100.7%. These results indicate that an increase in adenosine can be accurately and reproducibly detected by the ADA assay.

Screening of adenosine-producing strains

To verify whether this ADA assay can be used to quantify the amount of adenosine produced by different bacterial strains at once, a adenosine-producing strain was treated with 402 nm laser for 3 min, isolated on LB agar plate, and then 95 randomly picked colonies were cultured in 96-well deep-hole culture plate with control strains. These strains were then screened using ADA assay with 96-well plate.

The results were presented in Fig. 4 as a heat map and the data were shown in Table S2. The top four adenosine-producing mutants (B8, B9, B12 and A3) chosen by ADA assay were further tested by HPLC (Fig. 4B). The values of ADA assay and HPLC method has positively correlation for adenosine concentration. Though the values from ADA assay in 96-well plate deviated slightly from those determined by HPLC, the ADA assay is still a good method to exclude more than 95% of low-yielding strains.

Figure 4.

Figure 4

Open in a new tab

Screening high adenosine-producing strains using the ADA assay.A. Production of adenosine in a 96-well culture plate from randomly picked mutation strains. A1 represented for adenosine concentration of parent strain.B. Top four samples (B8, B9, B12 and A3) determined using the ADA assay were chosen to detect adenosine by HPLC. Each experiment run in triplicate.

The suitability of ADA assay for high-throughput screening (HTS) was also estimated. The screening window coefficient (Z′ factor) for this assay was 0.911 and 0.902 in M9 and diluted LB media (Table 1). These high values (maximum of 1.00 for a perfect assay) reflect the overall quality of this assay.

Discussion

An easy and simple assay for adenosine in this study was developed by coupling ADA and indophenol method to screen and isolate high adenosine-producing bacteria. The enzyme (ADA) constituting the assay can be readily obtained by over-expression in E. coli. The assay is a simple detection method as it only requires ADA in the assay mixture. It also has low detection limit, and is highly sensitive to low concentrations of substrate. This assay can be applied to analysis biological samples and allows easier and simpler measurements of adenosine in fermentation broth without any pretreatment. In comparison with the traditional qualitative and quantitative detection of adenosine using chromatography methods such as HPLC, which are expensive, laborious and low-throughput (102–104 colonies per week), the reported assay is high-throughput, quick, sensitive and highly adaptable systems (106–108 colonies per week) (Strege, 1999; Pham-Tuan et al., 2003). The methods developed for determination of adenosine in serum, urine or tissue (Kloor et al., 2000; Burgos et al., 2012; Helenius et al., 2012; Li et al., 2012; Wang et al., 2012; Zhang et al., 2013) have nice detection limit and linear relationship. However, the detection range is too narrow (see Table S1) and the test cost is too high for them to be used in detecting the adenosine in fermentation broth in large numbers of samples.

The cultivation medium and the metabolism by-products of the adenosine- producing strains are main factors that might affect the ADA assay to analyze and screen for a higher adenosine-producing strain. The result showed that modified M9 salt-based minimal medium has little influence on the ADA assay, while LB medium has a significant effect on the assay (Fig. 2). The adenosine in M9 medium should be detectable in the range of 0.054–10 mM. The sensitivity of this assay will decrease when adenosine is detected in complex medium containing yeast extract, peptone, tryptone or beef powder. As they all contained compounds with primary or secondary amino groups which strongly suppress the development of blue color in indophenol method (Ngo et al., 1982). However, the diluted complex medium had little effect on adenosine assay. Four main by-products, sodium pyruvate, sodium lactate, AMP and IMP, were investigated and it turned out that all of them had no effect on ADA assay. The adenosine also had no influence on ADA assay. However, some other metabolic substances have effect on the assay, for example, the ammonia contained in the fermentation broth samples. Therefore, the blank control experiments should be done to eliminate the background interference. As the by-products accumulated in fermentation will interfere the assay, an appropriate fermentation time (24 h) should be choose to screen adenosine-producing strains. This can eliminate the influence and at the mean time shorten the screening period.

Although the ADA was coupled to indophenol method, the coupling partner could be many other enzymes (e.g. GLDH) or methods that can determine ammonia concentration. These assays can also be used to quantify other biomolecules based on deaminase. Deoxyadenosine and adenosine are equally good substrates for ADA, which means the methods based on ADA are also suitable for high-throughput screening of deoxyadenosine-producing strains.

Experimental procedures

Materials and equipments

All chemical reagents were of analytical grade and purchased from Sigma-Aldrich (St Louis, MO, USA). Primerstar Taq polymerase was purchased from Takara and restriction endonuclease, T4 ligase and their corresponding buffers were purchased from New England Biolabs (NEB). Ninety-six-well microplates were purchased from Nunc. Ni-NTA agarose resins were supplied by GE Healthcare for His-tagged protein purification.

All polymerase chain reactions (PCR) were performed using a thermal cycler (DNA Engine; Bio-Rad, Hercules, CA, USA). Colorimetric assay were measured by a microplate reader (SpectraMax M2e, Molecular Devices, Sunnyvale, CA, USA). HPLC analysis was performed by Agilent 1260 (Agilent Technologies, Waldbronn, Germany).

Plasmids, bacterial strains and media

Plasmid pET28a was purchased from invitrogen. The host bacterial DH5α and BL21(DE3) were purchased from TransGen Biotech company for the construction, propagation and expression of plasmids. The adenosine-producing B. subtilis was reserved in our laboratory.

Luria Broth (LB) medium contains (per liter) 10 g tryptone, 5 g yeast extract, and 10 g NaCl. LB agar plates were prepared by adding 1.5% agar. M9 minimal salts medium contains (per liter) 12.8 g Na2HPO4·7H2O, 3 g KH2PO4, 0.5 g NaCl, 1 g (NH2)2CO, 1 mM MgSO4·7H2O, 0.1 mM CaCl2, 0.05 g tryptophan, micronutrient components (1 μM FeSO4·7H2O, 0.01 μM ZnSO4·7H2O, 0.08 μM MnCl2·4H2O, 0.4 μM H3BO4, 0.03 μM CoCl2·6H2O, 0.01 μM CuCl2·2H2O, and 3 nM Na2MoO4), and appropriate amounts of glucose and antibiotics.

Plasmid construction

Two primers were employed to amplify add gene from genomic DNA of E. coli 1655 and designed as follows: Ec-add-F (5′-CGCGGATCCATGATTGATACCACCCTGCC -3′) and Ec-add-R (5′-CCGGAATTCTTACTTCGC GGCGACTTTTT-3′). The PCR product was purified from agarose gel, digested with BamHI and EcoRI and subsequently ligated into a pET28a vector. E. coli DH5α cells with plasmids were cultured aerobically at 37°C in LB medium or on LB agar plates with 50 mg/l Kanamycin. The constructed pET28a-add was expressed in E. coli BL21(DE3).

Expression and purification of ADA

For the expression of ADA, E. coli BL21 (DE3) including pET28a-add plasmid was grown to an OD 600 of 0.6∼0.8 in LB (contained 50 mg/l Kanamycin) and then induced for 2 h by adding 1 mM isopropyl-1-thio-b-D-galactopyranoside (IPTG). Cells expressing ADA were harvested and cell pellet was suspended in the lysis buffer (50 mM NaH2PO4, pH 8.0, 300 mM NaCl, 10 mM imidazole, 10 mM β-mercaptoethanol), and then disrupted by sonication. The supernatant fraction was subjected to Ni-NTA agarose and equilibrated for 2 h in 4°C. By applying the mixture to the column, the unbound proteins were washed off the column while the bound proteins were eluted by the elute buffer (50 mM NaH2PO4, pH 8.0, 300 mM NaCl, 250 mM imidazole, 10 mM β-mercaptoethanol). The purified protein were dialyzed against a storage buffer (50 mM NaH2PO4, pH 8.0 and 1 mM DTT) for overnight in 4°C (Liu et al., 2014). The purified enzyme was subsequently mixed with 30% glycerinum and stored in −20°C before utilization.

ADA assay for adenosine detection

The featured product of adenosine assay used in this study is indophenol. The ammonia from the cleavage of adenosine will react with salicylate, hypochlorite and nitroprusside to form a diazonium salt (González-Rodríguez et al., 2002) with maximum absorption at 697 nm. The reaction mechanism was shown in Fig. 5.

Figure 5.

Figure 5

Open in a new tab

Scheme of the enzymatic assay for adenosine detection at 697 nm.

Standard adenosine was prepared in Milli-Q deonized water as stock solution and the determination was performed in a 96-well plate. The reaction mixture with the total volume of 225 μl. Firstly, 25 μl of adenosine samples were mixed with 100 μl 0.01 M phosphate-buffered saline (PBS) and appropriate amounts of the enzyme. The mixture was incubated for 20 min at 37°C, 50 μl reagent I (containing 68 g/l salicylic acid, 25 g/l sodium hydroxide and 2.2 g/l sodium nitroprusside) and 50 μl reagent II (containing 40.9 ml/l sodium hypochlorite ) were added to the above mixture and incubated for 30 min at 37°C. Then, the reaction mixture was diluted in proper ratio with water and measured at 697 nm using a microplate reader. The amount of salicylic acid, sodium hydroxide, sodium nitroprusside and sodium hypochlorite were optimized to improve the sensitivity of the assay. Absorbance measured at the end of the reaction was used to construct adenosine standard curves. The detection limit of the assay was defined as 3 times the standard deviation of adenosine-free blank samples (n = 20) (Kameya et al., 2014).

Substrate specificity for ADA assay

The effects of different ribonucleosides on ADA assay were examined. The reaction contained 2 mM ribonucleosides and performed as described above.

Fermentation and analysis of adenosine production

To determine whether this assay could be applied to the fermentation industry as a rapid and accurate tool for adenosine measuring, salt irons, medium nutrients which are commonly used in conventional microbiological culture media were examined to investigate their effects on the ADA assay. The reaction contained 2 mM adenosine and the assay was performed as described above.

The fed-batch fermentation was also processed in M9 minimal salts medium adding 4% glucose. The fermentation was performed in 250 ml Erlenmeyer flask containing 50 ml M9 medium. The flask was kept in a shaker incubator at 220 rpm and 37°C for 48 h. The biomass concentration was determined by the OD at 600 nm in a UV spectrophotometer. The concentration of adenosine in the cell free culture supernatant was measured using the above assay and HPLC. Samples, harvested at certain time of fermentation, were centrifuged at 13 000 rpm for 2 min at 20°C. The supernatants were filtered through a 0.22 μm membrane filter. An aliquot (10 μl) was injected and analyzed by the Agilent 1260 HPLC with a 5C18-250A column (Agilent, 4.6 mm id × 250 mm) thermostated at 35°C to separate the compounds. The mobile phase consists of water: acetonitrile (96:5 v/v) at a flow rate of 0.8 ml/min and the analytes were detected at 280 nm.

Z′ Factor

The screening window coefficient was determined as previously described (Zhang, 1999) using two extremes of the standard curve in different media. The following equation was used to calculate the corresponding factor Z′:

graphic file with name mbt20008-0230-m3.jpg 3

where μc+ and μc− are the mean value of absorbance of two extremes of the standard curve and σc+ and σc− are the standard deviation of the absorbance (with 99.73% confidence limit), respectively.

Conflict of interest

This work has been included in a patent application by Tianjin Institute of Industrial Biotechnology, Chinese Academy of Science.

Supporting Information

Fig. S1. The determination of different concentrations of adenosine using ADA assay in regular M9 medium.

Table S1. Comparison of detection range of previous published methods.

Table S2. Adenosine production of screening strains in 96-well plate.

mbt20008-0230-sd1.doc (131.5KB, doc)

References

  1. Asada M, Yanamoto K, Nakanishi K, Matsuno R, Kirnura A. Kamikubo T. Long term continuous ATP regeneration by enzymes of the alcohol fermentation pathway and kinases of yeast. Eur J Appl Microbiol Biotechnol. 1981;12:198–204. [Google Scholar]
  2. Burgos ES, Gulab SA, Cassera MB. Schramm VL. Luciferase-based assay for adenosine: application to S-Adenosyl-l-homocysteine hydrolase. Anal Chem. 2012;84:3593–3598. doi: 10.1021/ac203297z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chen X, Zhang C, Cheng J, Shi X, Li L, Zhang Z, et al. Enhancement of adenosine production by Bacillus subtilis CGMCC 4484 through metabolic flux analysis and simplified feeding strategies. Bioprocess Biosyst Eng. 2013;36:1851–1859. doi: 10.1007/s00449-013-0959-6. [DOI] [PubMed] [Google Scholar]
  4. Diaz J, Tornel PL. Martinez P. Reference intervals for blood ammonia in healthy subjects, determined by microdiffusion. Clin Chem. 1995;41:1048. [PubMed] [Google Scholar]
  5. Dienst SG. An ion exchange method for plasma ammonia concentration. J Lab Clin Med. 1961;58:149–155. [PubMed] [Google Scholar]
  6. Dong H. Zhang D. Current development in genetic engineering strategies of Bacillus species. Microb Cell Fact. 2014;13:63. doi: 10.1186/1475-2859-13-63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. da Fonseca-Wollheim F. Heinze KG. Which is the appropriate coenzyme for the measurement of ammonia with glutamate dehydrogenase? Eur J Clin Chem Clin Biochem. 1992;30:537–540. [PubMed] [Google Scholar]
  8. Fu B, Cao J, Jiang W. Wang L. A novel enzyme-free and label-free fluorescence aptasensor for amplified detection of adenosine. Biosens Bioelectron. 2013;44:52–56. doi: 10.1016/j.bios.2012.12.059. [DOI] [PubMed] [Google Scholar]
  9. González-Rodríguez J, Pérez-Juan P. Luque de Castro MD. Method for monitoring urea and ammonia in wine and must by flow injection–pervaporation. Anal Chim Acta. 2002;471:105–111. [Google Scholar]
  10. Helenius M, Jalkanen S. Yegutkin GG. Enzyme-coupled assays for simultaneous detection of nanomolar ATP, ADP, AMP, adenosine, inosine and pyrophosphate concentrations in extracellular fluids. Biochim Biophys Acta. 2012;1823:1967–1975. doi: 10.1016/j.bbamcr.2012.08.001. [DOI] [PubMed] [Google Scholar]
  11. Hisamatsu T, Okamoto S, Hashimoto M, Muramatsu T, Andou A, Uo M, et al. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease. PLoS ONE. 2012;7:e31131. doi: 10.1371/journal.pone.0031131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hu P, Zhu C, Jin L. Dong S. An ultrasensitive fluorescent aptasensor for adenosine detection based on exonuclease III assisted signal amplification. Biosens Bioelectron. 2012;34:83–87. doi: 10.1016/j.bios.2012.01.022. [DOI] [PubMed] [Google Scholar]
  13. Iosefsohn M. Hicks JM. Ektachem multilayer dry-film assay for ammonia evaluated. Clin Chem. 1985;31:2012–2014. [PubMed] [Google Scholar]
  14. Kameya M, Himi M. Asano Y. Rapid and selective enzymatic assay for l-methionine based on a pyrophosphate detection system. Anal Biochem. 2014;447:33–38. doi: 10.1016/j.ab.2013.11.002. [DOI] [PubMed] [Google Scholar]
  15. Kaminski PM. Proctor KG. Attenuation of no-reflow phenomenon, neutrophil activation, and reperfusion injury in intestinal microcirculation by topical adenosine. Circ Res. 1989;65:426–435. doi: 10.1161/01.res.65.2.426. [DOI] [PubMed] [Google Scholar]
  16. Kloor D, Yao K, Delabar U. Osswald H. Simple and sensitive binding assay for measurement of adenosine using reduced S-Adenosylhomocysteine hydrolase. Clin Chem. 2000;16:537–542. [PubMed] [Google Scholar]
  17. Lawson CS, Coltart DJ. Hearse DJ. ‘Dose'-dependency and temporal characteristics of protection by ischaemic preconditioning against ischaemia-induced arrhythmias in rat hearts. J Mol Cell Cardiol. 1993;25:1391–1402. doi: 10.1006/jmcc.1993.1156. [DOI] [PubMed] [Google Scholar]
  18. Li L-L, Ge P, Selvin PR. Lu Y. Direct detection of adenosine in undiluted serum using a luminescent aptamer sensor attached to a terbium complex. Anal Chem. 2012;84:7852–7856. doi: 10.1021/ac302167d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Liu YF, Li FR, Zhang XR, Cao GQ, Jiang WJ, Sun YX, et al. A fast and sensitive coupled enzyme assay for the measurement of l -threonine and application to high-throughput screening of threonine-overproducing strains. Enzyme Microb Technol. 2014;67:1–7. doi: 10.1016/j.enzmictec.2014.08.008. [DOI] [PubMed] [Google Scholar]
  20. Marzilli M, Orsini E, Marraccini P. Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation. 2000;101:2154–2159. doi: 10.1161/01.cir.101.18.2154. [DOI] [PubMed] [Google Scholar]
  21. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol. 1998;274:R577–R595. doi: 10.1152/ajpregu.1998.274.3.R577. [DOI] [PubMed] [Google Scholar]
  22. Mroz EA, Roman RJ. Lechene C. Fluorescence assay for picomole quantities of ammonia. Kidney Int. 1982;21:524–527. doi: 10.1038/ki.1982.56. [DOI] [PubMed] [Google Scholar]
  23. Ngo TT, Phan APH, Yam CF. Lenhoff HM. Interference in determination of ammonia with the hypochlorite-alkaline phenol method of Berthelot. Anal Chem. 1982;54:46–49. [Google Scholar]
  24. Nishiyama T, Karasawa M. Yamamoto K. Production of adenosine by a growth-improved mutant of Bacillus subtilis. Nippon Nogei Kagaku Kaishi. 1995;69:1341–1347. [Google Scholar]
  25. Nygaard P. Adenosine deaminase from Escherichia coli. Methods Enzymol. 1978;51:508–512. doi: 10.1016/s0076-6879(78)51070-7. [DOI] [PubMed] [Google Scholar]
  26. Olafsson B, Forman MB, Puett DW, Pou A, Cates CU, Friesinger GC. Virmani R. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation. 1987;76:1135–1145. doi: 10.1161/01.cir.76.5.1135. [DOI] [PubMed] [Google Scholar]
  27. Pham-Tuan H, Kaskavelis L, Daykin CA. Janssen HG. Method development in high-performance liquid chromatography for high-throughput profiling and metabonomic studies of biofluid samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;789:283–301. doi: 10.1016/s1570-0232(03)00077-1. [DOI] [PubMed] [Google Scholar]
  28. Roland KL, Powell FE. Turnbough CL., Jr Role of translation and attenuation in the control of pyrBI operon expression in Escherichia coli K-12. J Bacteriol. 1985;163:991–999. doi: 10.1128/jb.163.3.991-999.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sauer U, Cameron DC. Bailey JE. Metabolic capacity of Bacillus subtilis for the production of purine nucleosides, riboflavin, and folic acid. Biotechnol Bioeng. 1998;59:227–238. [PubMed] [Google Scholar]
  30. Strege MA. High-performance liquid chromatographic-electrospray ionization mass spectrometric analyses for the integration of natural products with modern high-throughput screening. J Chromatogr B Biomed Sci Appl. 1999;725:67–78. doi: 10.1016/s0378-4347(98)00553-2. [DOI] [PubMed] [Google Scholar]
  31. Talke H. Schubert GE. Enzymatisehe Harnstoffbestimmung in Blut und Serum im optisehen Test naeh WARBURG. Klin Wochenschr. 1961;43:174–175. doi: 10.1007/BF01484513. [DOI] [PubMed] [Google Scholar]
  32. Tanganelli E, Prencipe L, Bassi D, Cambiaghi S. Murador E. Enzymic assay of creatinine in serum and urine with creatinine iminohydrolase and glutamate dehydrogenase. Clin Chem. 1982;28:1461–1464. [PubMed] [Google Scholar]
  33. Taylor S, Ninjoor V, Dowd DM. Tappel AL. Cathepsin B2 measurement by sensitive fluorometric ammonia analysis. Anal Biochem. 1974;60:153–162. doi: 10.1016/0003-2697(74)90140-7. [DOI] [PubMed] [Google Scholar]
  34. Thomas DH, Rey M. Jackson PE. Determination of inorganic cations and ammonium in environmental waters by ion chromatography with a high-capacity cation-exchange column. J Chromatogr A. 2002;956:181–186. doi: 10.1016/s0021-9673(02)00141-3. [DOI] [PubMed] [Google Scholar]
  35. Wakisaka S, Tachiki T, Sung HC, Kumagai H, Tochikura T. Matsui S. A rapid assay method for ammonia using glutamine synthetase from glutamate-producing bacteria. Anal Biochem. 1987;163:117–122. doi: 10.1016/0003-2697(87)90101-1. [DOI] [PubMed] [Google Scholar]
  36. Wang H, Gong W, Tan Z, Yin X. Wang L. Label-free bifunctional electrochemiluminescence aptasensor for detection of adenosine and lysozyme. Electrochim Acta. 2012;76:416–423. [Google Scholar]
  37. Yamaguchi F, Etoh T, Takahashi M, Misaki H, Sakuraba H. Ohshima T. A new enzymatic cycling method for ammonia assay using NAD synthetase. Clin Chim Acta. 2005;352:165–173. doi: 10.1016/j.cccn.2004.09.011. [DOI] [PubMed] [Google Scholar]
  38. Yu WB, Gao SH, Yin CY, Zhou Y. Ye BC. Comparative transcriptome analysis of Bacillus subtilis responding to dissolved oxygen in adenosine fermentation. PLoS ONE. 2011;6:e20092. doi: 10.1371/journal.pone.0020092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Zhang H, Fu G. Zhang D. Cloning, characterization and production of a novel lysozyme by different expression hosts. J Microbiol Biotechnol. 2014;24:1405–1412. doi: 10.4014/jmb.1404.04039. [DOI] [PubMed] [Google Scholar]
  40. Zhang JH. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen. 1999;4:67–73. doi: 10.1177/108705719900400206. [DOI] [PubMed] [Google Scholar]
  41. Zhang K, Wang K, Xie M, Xu L, Zhu X, Pan S, et al. A new method for the detection of adenosine based on time-resolved fluorescence sensor. Biosens Bioelectron. 2013;49:226–230. doi: 10.1016/j.bios.2013.05.030. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Fig. S1. The determination of different concentrations of adenosine using ADA assay in regular M9 medium.

Table S1. Comparison of detection range of previous published methods.

Table S2. Adenosine production of screening strains in 96-well plate.

mbt20008-0230-sd1.doc (131.5KB, doc)

Articles from Microbial Biotechnology are provided here courtesy of Wiley

RESOURCES